Esperion Therapeutics
ESPR
#6656
Rank
$0.81 B
Marketcap
$3.18
Share price
0.00%
Change (1 day)
125.53%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): $79.38 Million USD

According to Esperion Therapeutics's latest financial reports the company's current earnings are $0.41 Billion USD. In 2025 the company made an earning of $63.76 Million USD, an increase over its 2024 earnings that were of $7.5 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $79.38 M24.51%
2025 $63.76 M749.49%
2024 $7.5 M-104.99%
2023 -$0.16 Billion-15.03%
2022 -$0.18 Billion-20.61%
2021 -$0.23 Billion84.28%
2020 -$0.13 Billion35.75%
2019 -$89.05 Million-55.71%
2018 -$0.21 Billion19.57%
2017 -$0.17 Billion125.39%
2016 -$74.61 Million51.43%
2015 -$49.27 Million36.45%
2014 -$36.11 Million43.55%
2013 -$25.16 Million145.26%
2012 -$10.26 Million
2002 -$29.24 Million-7.81%
2001 -$31.72 Million15.03%
2000 -$27.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.59 B 13,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$5.15 B 6,395.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-$0.54 Billion-775.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-$26.09 Million-132.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
$0.19 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38 B 385.70%๐Ÿ‡บ๐Ÿ‡ธ USA